Penumbra Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Penumbra Inc 公司

Penumbra, Inc. 是一家醫療保健公司。該公司設計、開發、製造和銷售產品，並擁有一系列產品，可解決市場上尚未滿足需求的棘手醫療狀況。該公司專注於開發、製造和銷售供專科醫生和醫療保健提供者使用的產品，以推動改善臨牀和健康結果。該公司專注於開發和構建其產品組合，包括血栓切除術、栓塞術、通路和沉浸式醫療保健技術。該公司關注的常見疾病包括肺栓塞、深靜脈血栓形成、外周動脈閉塞、缺血性中風、急性冠狀動脈綜合徵、與動靜脈移植或瘻相關的血栓、動脈瘤和出血性中風。該公司主要通過其在美國、歐洲、加拿大和澳大利亞的直銷組織以及在特定國際市場的分銷商向醫療保健提供者銷售其產品。

公司簡介

公司代碼PEN

公司名稱Penumbra Inc

上市日期Sep 18, 2015

成立日期2004

CEOMr. Adam Elsesser, J.D.

員工數量4500

證券類型Ordinary Share

年結日Sep 18

公司地址One Penumbra Place

城市ALAMEDA

上市交易所NYSE Consolidated

國家United States of America

郵編94502

電話15109952486

網址https://www.penumbrainc.com/

公司代碼PEN

上市日期Sep 18, 2015

成立日期2004

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Adam Elsesser, J.D.

Chairman of the Board, President, Chief Executive Officer

901.49K

+4.18%

Dr. Arani Bose, M.D.

Director

302.26K

-3.82%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

53.58K

-0.36%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.96K

-1.00%

Ms. Surbhi Sarna

Independent Director

3.15K

-1.84%

Ms. Maggie S. Yuen

Chief Financial Officer

--

Mr. Thomas C. (Tom) Wilder, III

Presiding Independent Director

--

Mr. Harpreet S. Grewal

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Adam Elsesser, J.D.

Chairman of the Board, President, Chief Executive Officer

901.49K

+4.18%

Dr. Arani Bose, M.D.

Director

302.26K

-3.82%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

53.58K

-0.36%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.96K

-1.00%

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Thrombectomy

815.48M

68.26%

Embolization and Access

379.14M

31.74%

地區USD

名稱

營收

佔比

United States

902.07M

75.51%

International

292.55M

24.49%

業務

地區

業務USD

名稱

營收

佔比

Thrombectomy

815.48M

68.26%

Embolization and Access

379.14M

31.74%

股東統計

更新時間: 4月26日週六

持股股東

股東類型

持股股東

股東統計

佔比

Fidelity Management & Research Company LLC

12.53%

The Vanguard Group, Inc.

9.41%

BlackRock Institutional Trust Company, N.A.

9.03%

Champlain Investment Partners, LLC

3.86%

T. Rowe Price Associates, Inc.

3.19%

Other

61.98%

持股股東

股東統計

佔比

Fidelity Management & Research Company LLC

12.53%

The Vanguard Group, Inc.

9.41%

BlackRock Institutional Trust Company, N.A.

9.03%

Champlain Investment Partners, LLC

3.86%

T. Rowe Price Associates, Inc.

3.19%

Other

61.98%

股東類型

股東統計

佔比

Investment Advisor

50.51%

Investment Advisor/Hedge Fund

32.26%

Hedge Fund

4.42%

Individual Investor

3.42%

Research Firm

1.59%

Pension Fund

1.51%

Sovereign Wealth Fund

0.68%

Bank and Trust

0.54%

Private Equity

0.19%

Other

4.87%

機構持股

更新時間: 1月20日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

838

36.86M

95.18%

-4.14M

2024Q4

834

37.02M

96.10%

-3.78M

2024Q3

813

37.33M

96.12%

-2.93M

2024Q2

796

37.57M

96.93%

+395.13K

2024Q1

777

35.67M

92.18%

-2.09M

2023Q4

759

36.33M

94.13%

-67.98K

2023Q3

737

35.15M

91.46%

-2.09M

2023Q2

719

36.20M

94.64%

-1.94M

2023Q1

681

37.31M

97.62%

-964.82K

2022Q4

661

36.89M

97.22%

+885.45K

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Fidelity Management & Research Company LLC

4.85M

12.6%

-93.71K

-1.89%

Dec 31, 2024

The Vanguard Group, Inc.

3.64M

9.46%

-25.90K

-0.71%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

3.50M

9.08%

+25.93K

+0.75%

Dec 31, 2024

Champlain Investment Partners, LLC

1.50M

3.88%

-52.02K

-3.36%

Dec 31, 2024

T. Rowe Price Associates, Inc.

1.23M

3.21%

-702.67K

-36.27%

Dec 31, 2024

State Street Global Advisors (US)

1.20M

3.12%

-33.45K

-2.71%

Dec 31, 2024

Fidelity Institutional Asset Management

965.15K

2.51%

+16.18K

+1.71%

Dec 31, 2024

Elsesser (Adam)

985.33K

2.56%

+22.75K

+2.36%

Mar 19, 2025

William Blair Investment Management, LLC

883.10K

2.29%

-98.21K

-10.01%

Dec 31, 2024

RTW Investments L.P.

862.45K

2.24%

+66.70K

+8.38%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

Motley Fool Small-Cap Growth ETF

3.6%

First Trust Health Care Alphadex Fund

2.08%

First Trust Indxx Medical Devices ETF

1.89%

Congress SMid Growth ETF

1.87%

Putnam Sustainable Future ETF

1.67%

Tema Neuroscience and Mental Health ETF

1.58%

ROBO Global Healthcare Technology & Innovation ETF

1.56%

SPDR S&P Health Care Equipment ETF

1.53%

Zacks Focus Growth ETF

1.2%

iShares U.S. Medical Devices ETF

1.13%

Motley Fool Small-Cap Growth ETF

佔比3.6%

First Trust Health Care Alphadex Fund

佔比2.08%

First Trust Indxx Medical Devices ETF

佔比1.89%

Congress SMid Growth ETF

佔比1.87%

Putnam Sustainable Future ETF

佔比1.67%

Tema Neuroscience and Mental Health ETF

佔比1.58%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.56%

SPDR S&P Health Care Equipment ETF

佔比1.53%

Zacks Focus Growth ETF

佔比1.2%

iShares U.S. Medical Devices ETF

佔比1.13%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Penumbra Inc

293.630USD

Penumbra Inc

293.630

概覽

公司